TransMedics Group Inc (NAS:TMDX)
$ 59.77 -1.25 (-2.05%) Market Cap: 2.01 Bil Enterprise Value: 2.24 Bil PE Ratio: 63.59 PB Ratio: 9.55 GF Score: 70/100

Transmedics Group Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 11:30PM GMT
Release Date Price: $18.9 (-2.73%)
K. Gong
JP Morgan Chase & Co, Research Division - Analyst

Okay. Good afternoon, everyone. My name is Allen Gong. I'm on the medical supplies and devices team here at JPMorgan. It's my pleasure to introduce Waleed Hassanein, the CEO of TransMedics. After his prepared remarks, we will have a breakout session down the hall to the left and around the corner in the Olympic room.

Waleed H. Hassanein
TransMedics Group, Inc. - Founder, CEO, President & Director

Thank you, Al. Good afternoon, everyone. We're very excited to be here today at JPMorgan conference. This is our safe harbor statement. TransMedics, as you may know, is in the exciting field of organ transplantation. It's a very unique field in medicine that TransMedics is leading a global revolution in for the last few years. To understand what TransMedics does and the impact of TransMedics' business on this field, I want to start by giving you a little bit of background of why transplant medicine is a unique space. It's one of the very few health care spaces where all stakeholders in the field of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot